上海医疗器械研究所和浙江医科大学附属第二医院及上海901厂的科研人员潜心合作，终于在第三代人工心脏双叶瓣膜研制上取得突破性进展。日前，两例在杭州接受全热解碳双叶型人工心脏瓣膜替换后的病人经临床观察一年后，康复情况良好。人工心脏瓣膜历经第一代笼球瓣、第二代草叶 Shanghai Institute of Medical Devices and the Second Affiliated Hospital of Zhejiang Medical University and the Shanghai 901 Plant devoted themselves to working together to achieve a breakthrough in the development of the third generation of artificial heart bifoil valves. A few days ago, two patients who had undergone a total pyrolysis carbon bifoliar prosthetic heart valve replacement in Hangzhou had recovered after a year of clinical observation. Artificial heart valve undergoes first-generation cage ball valve and second generation blade of grass